• N/A
    Market Cap
  • -40.68%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$8.85
$8.85
$8.85
1-Year Range
$8.33
$17.52
$8.85
Latest Close$8.85
Change
+$0.49 (+5.56%)
Volume150

Information as of 05/22/2026

Company Profile

Sysmex Corporation/ADR
https://www.sysmex.co.jp
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Medical Devices
1-5-1 Wakinohama-kaigandori, Kobe, Japan, 651-0073
81 78 265 0500

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Key Executives

  • Hisashi Ietsugu
  • Kaoru Asano
  • Iwane Matsui
  • Kenji Tachibana
  • Zuo Hui Peng

Current Ownership Distribution

  • Other560.3M (90.16%)
  • Mutual Funds61.1M (9.84%)
  • Institutions11,181 (0.002%)
  • Insiders0 (0.00%)